271 related articles for article (PubMed ID: 26237606)
1. Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells.
Ovchinnikov DA; Wolvetang EJ
J Clin Med; 2014 Dec; 3(4):1357-72. PubMed ID: 26237606
[TBL] [Abstract][Full Text] [Related]
2. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
4. Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.
Hawkins KE; Duchen M
World J Stem Cells; 2019 May; 11(5):236-253. PubMed ID: 31171953
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
Atkinson-Dell R; Mohamet L
Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
[TBL] [Abstract][Full Text] [Related]
6. Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
Devineni A; Tohme S; Kody MT; Cowley RA; Harris BT
Am J Stem Cells; 2016; 5(3):99-106. PubMed ID: 27853631
[TBL] [Abstract][Full Text] [Related]
7. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
Lee C; Willerth SM; Nygaard HB
Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
[TBL] [Abstract][Full Text] [Related]
8. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
9. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived iPSCs, a reliable
Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
[TBL] [Abstract][Full Text] [Related]
11. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.
Tong G; Izquierdo P; Raashid RA
Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989
[TBL] [Abstract][Full Text] [Related]
12. Human stem cell transplantation models of Alzheimer's disease.
Ifediora N; Canoll P; Hargus G
Front Aging Neurosci; 2024; 16():1354164. PubMed ID: 38450383
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
14. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
[TBL] [Abstract][Full Text] [Related]
15. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
Riemens RJM; Kenis G; van den Beucken T
Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
[TBL] [Abstract][Full Text] [Related]
16. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
17. Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges.
Israel MA; Goldstein LS
Genome Med; 2011 Jul; 3(7):49. PubMed ID: 21867573
[TBL] [Abstract][Full Text] [Related]
18. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
Young JE; Goldstein LSB
Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
[TBL] [Abstract][Full Text] [Related]
19. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
Guo W; Fumagalli L; Prior R; Van Den Bosch L
Front Neurosci; 2017; 11():671. PubMed ID: 29326542
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
